These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14366837)

  • 21. [Hemolysis in rosettes by Hemophilus pertussis and Hemophilus parapertussis cultured on Bordet-Gengou medium].
    BERTOYE A; COURTIEU AL; GILLY R
    Ann Inst Pasteur (Paris); 1954 Oct; 87(4):469-70. PubMed ID: 13218388
    [No Abstract]   [Full Text] [Related]  

  • 22. [Studies on Hemophilus pertussis (Border-Gengou). III. Coagulase activity in other Hemophilus species; comparative studies with Micrococcus pyogenes aureus].
    BILLAUDELLE H
    Acta Pathol Microbiol Scand; 1955; 37(5):434-40. PubMed ID: 13301721
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies of the reaction of the living body to pertussis vaccine, with special reference to electromyographic experiments with the intercostal muscles. II. Electromyogram of the intercostal muscles by inoculation with Hemophilus pertussis type I and Hemophilus pertussis toxin after Hemophilus pertussis vaccination].
    KURODA I
    Paediatr Jpn; 1961 Jun; 65():643-8. PubMed ID: 13755302
    [No Abstract]   [Full Text] [Related]  

  • 24. Some growth requirements of Haemophilus influenzas and Haemophilus pertussis.
    BRUMFITT W
    J Pathol Bacteriol; 1959 Jan; 77(1):95-100. PubMed ID: 13621337
    [No Abstract]   [Full Text] [Related]  

  • 25. The haemagglutinin of Haemophilus pertussis; haemagglutinin as a protective antigen in experimental murine pertussis.
    KEOGH EV; NORTH EA
    Aust J Exp Biol Med Sci; 1948 Jul; 26(Pt 4):315-22. PubMed ID: 18880597
    [No Abstract]   [Full Text] [Related]  

  • 26. Hemophilus pertussis soluble antigen and complement fixing antibodies.
    PARFENTJEV IA; VIRION ME
    J Immunol; 1948 Sep; 60(1):167-71. PubMed ID: 18881078
    [No Abstract]   [Full Text] [Related]  

  • 27. The immunological relation between Haemophilus pertussis toxic filtrates and Haemophilus pertussis extracted toxin.
    BROWN AM
    J Gen Microbiol; 1949 Jan; 3(1):vii. PubMed ID: 18225039
    [No Abstract]   [Full Text] [Related]  

  • 28. The separation of the histamine-sensitizing factor from the protective antigens of Bordetella pertussis.
    DOLBY JM
    Immunology; 1958 Oct; 1(4):328-37. PubMed ID: 13610416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experience in diffusion analysis of antigens and antibodies. III. Study of hemophilus pertussis antigens].
    CHISTOVICH GN
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Apr; 27(4):17-22. PubMed ID: 13338794
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunoelectron microscopy of antigens of Bordetella pertussis using monoclonal antibodies to agglutinogens 2 and 3, filamentous haemagglutinin, pertussis toxin, pertactin and adenylate cyclase toxin.
    Blom J; Heron I; Hendley JO
    APMIS; 1994 Sep; 102(9):681-9. PubMed ID: 7946271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The altered reactivity of mice after immunization with Hemophilus pertussis vaccine.
    KIND LS
    J Immunol; 1953 Apr; 70(4):411-20. PubMed ID: 13035134
    [No Abstract]   [Full Text] [Related]  

  • 32. Amino acid metabolism in the genus Bordetella.
    ROWATT E
    J Gen Microbiol; 1955 Dec; 13(3):552-60. PubMed ID: 13278505
    [No Abstract]   [Full Text] [Related]  

  • 33. The preparation of highly potent endotoxin of Hemophilus pertussis.
    SMOLENS J; FLAVELL EH
    J Immunol; 1947 Oct; 57(2):173-7. PubMed ID: 20266866
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on the antigenic relation between H. pertussis. H. parapertussis and Br. bronchiseptica with special reference to the complement fixation test.
    OGONUKI M
    Kitasato Arch Exp Med; 1953 Sep; 26(1):41-53. PubMed ID: 13175377
    [No Abstract]   [Full Text] [Related]  

  • 35. Charcoal agar culture medium for preparing Hemophilus pertussis vaccine.
    POWELL HM; CULBERTSON CG; ENSMINGER PW
    Public Health Rep (1896); 1951 Mar; 66(11):346-8. PubMed ID: 14816499
    [No Abstract]   [Full Text] [Related]  

  • 36. Secretory IgA against pertussis toxin and surface structures of Bordetella pertussis in saliva of children with culture proven pertussis.
    Frühwirth M; Wolf H; Heininger H; Guggenbichler JP; Stehr E
    Adv Exp Med Biol; 1995; 371B():777-83. PubMed ID: 7502896
    [No Abstract]   [Full Text] [Related]  

  • 37. Antigenic structures of Haemophilus aegyptius and Haemophilus influenzae demonstrated by the gel precipitation technique.
    OLITZKI AL; SULITZEANU A
    J Bacteriol; 1959 Mar; 77(3):264-9. PubMed ID: 13641185
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of pertussigen (pertussis toxin) on the mouse protective activity of vaccines made from Bordetella species.
    Munoz JJ; Peacock MG
    Microbiol Immunol; 1989; 33(4):341-55. PubMed ID: 2549344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A soluble antigen of phase 1 Hemophilus pertussis. I. Mouse protection test of filtrate or supernatant of cultures in a medium without soluble starch or carbon particles.
    KUWAJIMA Y; MASUI M; ASANO A; MATSUI T
    J Immunol; 1956 Mar; 76(3):175-80. PubMed ID: 13306951
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the serology of Bordetella pertusis. 3. Biological investigations of antigen fractions of ultrasonic extract obtained by column chromatography on DEAE-cellulose (author's transl)].
    Mebel S; Mucke W; Lapaeva IA; Zakharova MS
    Zentralbl Bakteriol Orig A; 1974 Feb; 226(2):241-7. PubMed ID: 4133229
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.